Concepedia

Andriy Derkach

AD

64

Publications

3.3K

Citations

31

H-Index

2012

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

National Cancer Institute

Sylvester Comprehensive Cancer Center

Cornell University

University of Miami

Andriy Derkach is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

2012–2024

64

Publications

64

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

Justin Jee, Michael B. Foote, Melissa Lumish et al. · Journal of Clinical Oncology · 2020 · 263 citations · Full text

Identifying biomarkers of dietary patterns by using metabolomics

Mary C. Playdon, Steven C. Moore, Andriy Derkach et al. · American Journal of Clinical Nutrition · 2016 · 211 citations · Full text

, , +6

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Maximilian Stahl, Kamal Menghrajani, Andriy Derkach et al. · Blood Advances · 2021 · 181 citations · Full text

Clonal hematopoiesis is associated with risk of severe Covid-19

Kelly L. Bolton, Youngil Koh, Michael B. Foote et al. · Nature Communications · 2021 · 135 citations · Full text

Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure

Brian Ball, Christopher Famulare, Eytan M. Stein et al. · Blood Advances · 2020 · 127 citations · Full text

, , +15

Rows per page

1–5 of 64